FI881223A - Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi - Google Patents
Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi Download PDFInfo
- Publication number
- FI881223A FI881223A FI881223A FI881223A FI881223A FI 881223 A FI881223 A FI 881223A FI 881223 A FI881223 A FI 881223A FI 881223 A FI881223 A FI 881223A FI 881223 A FI881223 A FI 881223A
- Authority
- FI
- Finland
- Prior art keywords
- aminotetrahydroacridines
- preparation
- therapeutically active
- related compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
- C07D219/12—Amino-alkylamino radicals attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2673087A | 1987-03-17 | 1987-03-17 | |
US2673087 | 1987-03-17 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI881223A0 FI881223A0 (fi) | 1988-03-15 |
FI881223A true FI881223A (fi) | 1988-09-18 |
FI91401B FI91401B (fi) | 1994-03-15 |
FI91401C FI91401C (fi) | 1994-06-27 |
Family
ID=21833471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI881223A FI91401C (fi) | 1987-03-17 | 1988-03-15 | Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi |
Country Status (15)
Country | Link |
---|---|
US (1) | US5391553A (fi) |
EP (1) | EP0282959A3 (fi) |
JP (1) | JP2888485B2 (fi) |
KR (1) | KR960015001B1 (fi) |
AU (2) | AU633668B2 (fi) |
CA (1) | CA1318675C (fi) |
DK (1) | DK172864B1 (fi) |
FI (1) | FI91401C (fi) |
HU (1) | HU201018B (fi) |
IL (1) | IL85741A (fi) |
NO (1) | NO173498C (fi) |
NZ (1) | NZ223875A (fi) |
PH (1) | PH25124A (fi) |
PT (1) | PT86986B (fi) |
ZA (1) | ZA881865B (fi) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL87861A0 (en) * | 1987-10-05 | 1989-03-31 | Pfizer | 4-aminopyridine derivatives |
US5202440A (en) * | 1987-10-05 | 1993-04-13 | Pfizer Inc. | Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines |
US5008853A (en) | 1987-12-02 | 1991-04-16 | Xerox Corporation | Representation of collaborative multi-user activities relative to shared structured data objects in a networked workstation environment |
DE3889302T2 (de) | 1987-12-03 | 1994-10-20 | Mitsubishi Chem Ind | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. |
US4868177A (en) * | 1988-11-09 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use |
KR0156241B1 (ko) * | 1988-11-16 | 1998-11-16 | 도날드 알.토센 | 하이드록시-1,2,3,4-테트라하이드로아미노아크리딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물 |
JP2720517B2 (ja) * | 1989-05-31 | 1998-03-04 | 三菱化学株式会社 | 9―アシルアミノーテトラヒドロアクリジン誘導体および該誘導体を有効成分とする記憶障害改善剤 |
US4994452A (en) * | 1989-11-28 | 1991-02-19 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds |
US5112829A (en) * | 1989-11-28 | 1992-05-12 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds |
RU2024509C1 (ru) * | 1991-05-07 | 1994-12-15 | Всероссийский научный центр по безопасности биологически активных веществ | Производные 9-аминоакридина или их соли с органическими или неорганическими кислотами, проявляющие психотропную, антиамнестическую и липидрегулирующую активность |
GB9524346D0 (en) * | 1995-11-29 | 1996-01-31 | Univ Strathclyde | Polycyclic compounds |
US5783584A (en) * | 1995-12-11 | 1998-07-21 | Mayo Foundation For Medical Education And Research | THA analogs useful as cholinesterase inhibitors |
US5929093A (en) * | 1996-06-13 | 1999-07-27 | Mayo Foundation For Medical Education And Research | Bifunctional acetylcholinesterase reactivators |
TW521072B (en) * | 1997-06-02 | 2003-02-21 | Meiji Seika Kaisha | 4-quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture |
JP4685742B2 (ja) * | 1997-06-02 | 2011-05-18 | 明治製菓株式会社 | 4−キノリノール誘導体及びこれを有効成分として含有する農園芸用殺菌剤 |
ES2144353B1 (es) * | 1997-12-26 | 2001-01-01 | Consejo Superior Investigacion | Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion. |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
ES2168926B1 (es) * | 1999-12-14 | 2003-10-16 | Prous Science S A | Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente. |
CA2456594A1 (en) * | 2001-08-06 | 2003-02-20 | Mitsubishi Pharma Corporation | Preventives/remedies for cholinergic neuropathy |
KR101063605B1 (ko) * | 2003-01-08 | 2011-09-07 | 미쓰비시 타나베 파마 코퍼레이션 | 정신분열증 치료제 |
WO2011100373A1 (en) * | 2010-02-09 | 2011-08-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
CN102219740B (zh) * | 2010-09-10 | 2013-02-13 | 长春华洋高科技有限公司 | 1,2,3,4,5,6,7,8-八氢-9-苯乙酰胺基吖啶及制备方法和药用用途 |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ, インコーポレイテッド | 認知機能を改善するための方法および組成物 |
RU2567388C1 (ru) * | 2014-12-10 | 2015-11-10 | Открытое акционерное общество "Нижегородский химико-фармацевтический завод" | Способ получения 9-бутиламино-3,3-диметил-3,4-дигидроакридин-1(2н)-она гидрохлорида |
WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
AU2016302144B2 (en) * | 2015-08-03 | 2020-10-08 | Bristol-Myers Squibb Company | Heterocyclic compounds useful as modulators of TNF alpha |
KR101953366B1 (ko) | 2018-12-26 | 2019-02-28 | 정종문 | 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법 |
CN111704576A (zh) * | 2020-06-17 | 2020-09-25 | 菏泽学院 | 一种轴手性9-芳基四氢吖啶的合成方法及应用 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3232945A (en) * | 1962-08-13 | 1966-02-01 | S E Massengill Company | 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines |
US3318896A (en) * | 1963-12-05 | 1967-05-09 | Squibb & Sons Inc | Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines |
US3318895A (en) * | 1963-12-05 | 1967-05-09 | Squibb & Sons Inc | Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines |
BE658695A (fi) * | 1964-02-03 | 1965-07-22 | ||
US3580915A (en) * | 1968-09-16 | 1971-05-25 | American Home Prod | 1,2,3,4-tetrahydrobenzol(b)(1,6)naphthyridine derivatives |
US3541066A (en) * | 1968-09-16 | 1970-11-17 | American Home Prod | 2,3-dihydro-1,4-ethanobenzo(b)(1,5)naphthyridine derivatives |
US3647800A (en) * | 1970-04-30 | 1972-03-07 | American Home Prod | 10-substituted - 1 2 3 4 - tetrahydrobenzo(b)(1 6)naphthyridines useful as cns depressants |
US3637706A (en) * | 1970-04-30 | 1972-01-25 | American Home Prod | 10-(4 - (lower)alkylpiperazino) - 1 2 3 4-tetrahydrobenzo(b)(1 6) naphthyridine derivatives useful as cns depressants |
US3657233A (en) * | 1970-04-30 | 1972-04-18 | American Home Prod | 10-morpholino-1 2 3 4-tetrahydrobenzo(b)(1 6)naphthyridine derivatives |
US3674790A (en) * | 1970-05-01 | 1972-07-04 | American Home Prod | 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants |
ES431307A1 (es) * | 1973-11-16 | 1976-09-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos derivados de quinoleina. |
US4108998A (en) * | 1976-11-08 | 1978-08-22 | American Home Products Corp. | Furo[3,4-b]quinoline derivatives and pharmaceutical compositions and methods employing them |
JPS6147466A (ja) * | 1984-08-10 | 1986-03-07 | Dainippon Pharmaceut Co Ltd | アミン誘導体 |
US4631286A (en) * | 1984-10-25 | 1986-12-23 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
US4695573A (en) * | 1984-10-25 | 1987-09-22 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
DE3582995D1 (de) * | 1984-10-25 | 1991-07-04 | Hoechst Roussel Pharma | 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel. |
US4816456A (en) * | 1986-10-01 | 1989-03-28 | Summers William K | Administration of monoamine acridines in cholinergic neuronal deficit states |
EP0268871A1 (en) * | 1986-10-31 | 1988-06-01 | Sumitomo Pharmaceuticals Company, Limited | Quinoline derivatives |
AU634004B2 (en) * | 1987-03-17 | 1993-02-11 | Hoechst Marion Roussel, Inc. | Intermediates for substituted 9-amino-tetrahydro-acridines, a process for their preparation and their use as medicaments |
US4762841A (en) * | 1987-03-30 | 1988-08-09 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes) |
US4851536A (en) * | 1987-05-07 | 1989-07-25 | American Home Products Corporation | Cyclohexylquinolines as inhibitors of interleukin 1 |
DE3889302T2 (de) * | 1987-12-03 | 1994-10-20 | Mitsubishi Chem Ind | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. |
US4868177A (en) * | 1988-11-09 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use |
US4999430A (en) * | 1989-07-31 | 1991-03-12 | Warner-Lambert Company | Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine |
GB8917568D0 (en) * | 1989-08-01 | 1989-09-13 | Morton Oswald | Compounds |
-
1988
- 1988-03-15 EP EP88104042A patent/EP0282959A3/en not_active Withdrawn
- 1988-03-15 NZ NZ223875A patent/NZ223875A/xx unknown
- 1988-03-15 FI FI881223A patent/FI91401C/fi not_active IP Right Cessation
- 1988-03-15 PH PH36638A patent/PH25124A/en unknown
- 1988-03-15 IL IL8574188A patent/IL85741A/en not_active IP Right Cessation
- 1988-03-16 CA CA000561561A patent/CA1318675C/en not_active Expired - Lifetime
- 1988-03-16 KR KR1019880002729A patent/KR960015001B1/ko not_active IP Right Cessation
- 1988-03-16 NO NO881164A patent/NO173498C/no unknown
- 1988-03-16 ZA ZA881865A patent/ZA881865B/xx unknown
- 1988-03-16 HU HU881254A patent/HU201018B/hu unknown
- 1988-03-16 PT PT86986A patent/PT86986B/pt not_active IP Right Cessation
- 1988-03-16 JP JP63060665A patent/JP2888485B2/ja not_active Expired - Lifetime
- 1988-03-16 DK DK198801435A patent/DK172864B1/da not_active IP Right Cessation
- 1988-09-14 US US07/244,212 patent/US5391553A/en not_active Expired - Lifetime
-
1990
- 1990-12-19 AU AU68240/90A patent/AU633668B2/en not_active Ceased
- 1990-12-19 AU AU68241/90A patent/AU635370B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU633668B2 (en) | 1993-02-04 |
FI91401C (fi) | 1994-06-27 |
NO173498C (no) | 1993-12-22 |
JPS63238063A (ja) | 1988-10-04 |
AU1314188A (en) | 1988-09-15 |
NO881164L (no) | 1988-09-19 |
AU608300B2 (en) | 1991-03-28 |
HU201018B (en) | 1990-09-28 |
KR880011111A (ko) | 1988-10-26 |
AU6824090A (en) | 1991-05-02 |
JP2888485B2 (ja) | 1999-05-10 |
PT86986B (pt) | 1992-06-30 |
AU6824190A (en) | 1991-03-14 |
DK143588D0 (da) | 1988-03-16 |
PT86986A (pt) | 1988-04-01 |
NO173498B (no) | 1993-09-13 |
KR960015001B1 (ko) | 1996-10-23 |
AU635370B2 (en) | 1993-03-18 |
PH25124A (en) | 1991-02-19 |
IL85741A0 (en) | 1988-08-31 |
FI881223A0 (fi) | 1988-03-15 |
NZ223875A (en) | 1991-01-29 |
FI91401B (fi) | 1994-03-15 |
HUT46672A (en) | 1988-11-28 |
US5391553A (en) | 1995-02-21 |
EP0282959A2 (en) | 1988-09-21 |
EP0282959A3 (en) | 1989-05-31 |
DK172864B1 (da) | 1999-08-23 |
CA1318675C (en) | 1993-06-01 |
IL85741A (en) | 1996-05-14 |
DK143588A (da) | 1988-09-18 |
NO881164D0 (no) | 1988-03-16 |
ZA881865B (en) | 1988-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI881223A (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi | |
FI883064A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
FI880941A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi | |
FI96420C (fi) | Menetelmä terapeuttisesti aktiivisten bis-(hydroksimetyyli)syklobutyylipuriinien ja -pyrimidiinien valmistamiseksi | |
NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
FI860484A (fi) | Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi | |
FI92934B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi | |
FI873205A0 (fi) | Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
FI90769C (fi) | Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi | |
NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
FI875235A (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia tetrahydro(imidatsolyylimetyyli)-4H-karbatsol-4-oneja | |
FI893448A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivinen ranitidiinisuola | |
FI930723A (fi) | Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi | |
FI880869A (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
NO176273C (no) | Analogifremgangsmåte for fremstilling av aktive substituerte benzamider | |
FI884471A0 (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
FI93215C (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi | |
FI893936A (fi) | Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
FI98461B (fi) | Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi | |
NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
PC | Transfer of assignment of patent |
Owner name: HOECHST MARION ROUSSEL, INC. |
|
MM | Patent lapsed |
Owner name: HOECHST MARION ROUSSEL INC., INC. |
|
MA | Patent expired |